<?xml version="1.0"?>
<dataset>
    <table name="journals">
        <column>id</column>
        <column>issn</column>
        <column>title</column>
        <column>abbr</column>
        <row>
            <value>1</value>
            <value>1932-6203</value>
            <value>PloS one</value>
            <value>PLoS ONE</value>
        </row>
        <row>
            <value>194</value>
            <value>0142-6338</value>
            <value>Journal of tropical pediatrics</value>
            <value>J Trop Pediatr</value>
        </row>
        <row>
            <value>197</value>
            <value>1022-386X</value>
            <value>Journal of the College of Physicians and Surgeons--Pakistan : JCPSP</value>
            <value>J Coll Physicians Surg Pak</value>
        </row>
        <row>
            <value>199</value>
            <value>0019-6061</value>
            <value>Indian pediatrics</value>
            <value>Indian Pediatr</value>
        </row>
        <row>
            <value>239</value>
            <value>1471-0528</value>
            <value>BJOG : an international journal of obstetrics and gynaecology</value>
            <value>BJOG</value>
        </row>
        <row>
            <value>240</value>
            <value>1873-1708</value>
            <value>Reproductive toxicology (Elmsford, N.Y.)</value>
            <value>Reprod Toxicol</value>
        </row>
        <row>
            <value>241</value>
            <value>1878-5867</value>
            <value>Steroids</value>
            <value>Steroids</value>
        </row>
        <row>
            <value>242</value>
            <value>1879-3231</value>
            <value>Theriogenology</value>
            <value>Theriogenology</value>
        </row>
    </table>
    <table name="articles">
        <column>id</column>
        <column>indexer_id</column>
        <column>volume</column>
        <column>issue</column>
        <column>pages</column>
        <column>year</column>
        <column>month</column>
        <column>day</column>
        <column>journal_id</column>
        <column>title</column>
        <column>pub_status</column>
        <row>
            <value>1</value>
            <value>PMID25036370</value>
            <value>9</value>
            <value>7</value>
            <value>e101200</value>
            <value>2014</value>
            <value></value>
            <value></value>
            <value>1</value>
            <value>Production of the Escherichia coli Common Pilus by Uropathogenic E. coli Is Associated with Adherence
                to HeLa and HTB-4 Cells and Invasion of Mouse Bladder Urothelium.
            </value>
            <value>1</value>
        </row>
        <row>
            <value>243</value>
            <value>PMID16014764</value>
            <value>51</value>
            <value>4</value>
            <value>236-9</value>
            <value>2005</value>
            <value>Aug</value>
            <value></value>
            <value>194</value>
            <value>Pancytopenia in children: etiological profile.</value>
            <value>1</value>
        </row>
        <row>
            <value>246</value>
            <value>PMID18460245</value>
            <value>18</value>
            <value>3</value>
            <value>163-7</value>
            <value>2008</value>
            <value>Mar</value>
            <value></value>
            <value>197</value>
            <value>Etiological spectrum of pancytopenia based on bone marrow examination in children.</value>
            <value>1</value>
        </row>
        <row>
            <value>248</value>
            <value>PMID2055619</value>
            <value>28</value>
            <value>1</value>
            <value>79-81</value>
            <value>1991</value>
            <value>Jan</value>
            <value></value>
            <value>199</value>
            <value>Bone marrow necrosis and pancytopenia associated with gram negative septicemia.</value>
            <value>1</value>
        </row>
        <row>
            <value>306</value>
            <value>PMID25088680</value>
            <value></value>
            <value></value>
            <value></value>
            <value>2014</value>
            <value>Aug</value>
            <value>4</value>
            <value>239</value>
            <value>The risk of uterine rupture is not increased with single- compared with double-layer closure: a
                Swedish cohort study.
            </value>
            <value>0</value>
        </row>
        <row>
            <value>307</value>
            <value>PMID25088246</value>
            <value></value>
            <value></value>
            <value></value>
            <value>2014</value>
            <value>Jul</value>
            <value>31</value>
            <value>240</value>
            <value>Distinguishing between maternally-mediated and directly embryotoxic modes-of-action for
                postimplantation loss induced in rats by 2-amino-2-methylpropanol.
            </value>
            <value>0</value>
        </row>
        <row>
            <value>308</value>
            <value>PMID25087944</value>
            <value></value>
            <value></value>
            <value></value>
            <value>2014</value>
            <value>Jul</value>
            <value>31</value>
            <value>241</value>
            <value>Ospemifene: A First-in-Class, Non-hormonal Selective Estrogen Receptor ModulatorApproved forthe
                Treatment of Dyspareunia Associated with Vulvar and Vaginal Atrophy.
            </value>
            <value>0</value>
        </row>
        <row>
            <value>309</value>
            <value>PMID25087046</value>
            <value></value>
            <value></value>
            <value></value>
            <value>2014</value>
            <value>Jun</value>
            <value>30</value>
            <value>242</value>
            <value>VEGF system expression by immunohistochemistry and real-time RT-PCR study on collared peccary
                placenta.
            </value>
            <value>0</value>
        </row>

        <!-- To check author table and abstract table -->
        <row>
            <value>300</value>
            <value>PMID25088681</value>
            <value></value>
            <value></value>
            <value></value>
            <value>2014</value>
            <value>Aug</value>
            <value>4</value>
            <value>239</value>
            <value>Blah! Blah! Blah!
            </value>
            <value>0</value>
        </row>
    </table>
    <table name="article_authors">
        <column>id</column>
        <column>article_id</column>
        <column>position</column>
        <column>last_name</column>
        <column>fore_name</column>
        <column>initials</column>
        <row>
            <value>1</value>
            <value>1</value>
            <value>1</value>
            <value>Salda</value>
            <value>Zeus</value>
            <value>Z</value>
        </row>
        <row>
            <value>2</value>
            <value>1</value>
            <value>2</value>
            <value>De la Cruz</value>
            <value>Miguel A</value>
            <value>MA</value>
        </row>
        <row>
            <value>3</value>
            <value>1</value>
            <value>3</value>
            <value>Carrillo-Casas</value>
            <value>Erika Margarita</value>
            <value>EM</value>
        </row>
        <row>
            <value>4</value>
            <value>1</value>
            <value>4</value>
            <value>Dur</value>
            <value>Laura</value>
            <value>L</value>
        </row>
        <row>
            <value>5</value>
            <value>1</value>
            <value>5</value>
            <value>Zhang</value>
            <value>Yushan</value>
            <value>Y</value>
        </row>
        <row>
            <value>6</value>
            <value>1</value>
            <value>6</value>
            <value>Hern&#x1BA4;ez-Castro</value>
            <value>Rigoberto</value>
            <value>R</value>
        </row>
        <row>
            <value>7</value>
            <value>1</value>
            <value>7</value>
            <value>Puente</value>
            <value>Jos&#x980C;</value>
            <value>JL</value>
        </row>
        <row>
            <value>8</value>
            <value>1</value>
            <value>8</value>
            <value>Daaka</value>
            <value>Yehia</value>
            <value>Y</value>
        </row>
        <row>
            <value>9</value>
            <value>1</value>
            <value>9</value>
            <value>Gir</value>
            <value>Jorge A</value>
            <value>JA</value>
        </row>
        <row>
            <value>1576</value>
            <value>243</value>
            <value>1</value>
            <value>Bhatnagar</value>
            <value>Shishir Kumar</value>
            <value>SK</value>
        </row>
        <row>
            <value>1577</value>
            <value>243</value>
            <value>2</value>
            <value>Chandra</value>
            <value>Jagdish</value>
            <value>J</value>
        </row>
        <row>
            <value>1578</value>
            <value>243</value>
            <value>3</value>
            <value>Narayan</value>
            <value>Shashi</value>
            <value>S</value>
        </row>
        <row>
            <value>1579</value>
            <value>243</value>
            <value>4</value>
            <value>Sharma</value>
            <value>Sunita</value>
            <value>S</value>
        </row>
        <row>
            <value>1580</value>
            <value>243</value>
            <value>5</value>
            <value>Singh</value>
            <value>Varinder</value>
            <value>V</value>
        </row>
        <row>
            <value>1581</value>
            <value>243</value>
            <value>6</value>
            <value>Dutta</value>
            <value>Ashok Kumar</value>
            <value>AK</value>
        </row>
        <row>
            <value>1593</value>
            <value>246</value>
            <value>1</value>
            <value>Memon</value>
            <value>Shazia</value>
            <value>S</value>
        </row>
        <row>
            <value>1594</value>
            <value>246</value>
            <value>2</value>
            <value>Shaikh</value>
            <value>Salma</value>
            <value>S</value>
        </row>
        <row>
            <value>1595</value>
            <value>246</value>
            <value>3</value>
            <value>Nizamani</value>
            <value>M Akbar A</value>
            <value>MA</value>
        </row>
        <row>
            <value>1601</value>
            <value>248</value>
            <value>1</value>
            <value>Garewal</value>
            <value>G</value>
            <value>G</value>
        </row>
        <row>
            <value>1602</value>
            <value>248</value>
            <value>2</value>
            <value>Marwaha</value>
            <value>N</value>
            <value>N</value>
        </row>
        <row>
            <value>1603</value>
            <value>248</value>
            <value>3</value>
            <value>Marwaha</value>
            <value>R K</value>
            <value>RK</value>
        </row>
        <row>
            <value>1604</value>
            <value>248</value>
            <value>4</value>
            <value>Das</value>
            <value>K C</value>
            <value>KC</value>
        </row>
        <row>
            <value>1923</value>
            <value>306</value>
            <value>1</value>
            <value>Hesselman</value>
            <value>S</value>
            <value>S</value>
        </row>
        <row>
            <value>1924</value>
            <value>306</value>
            <value>2</value>
            <value>H&#xF6;gberg</value>
            <value>U</value>
            <value>U</value>
        </row>
        <row>
            <value>1925</value>
            <value>306</value>
            <value>3</value>
            <value>Ekholm-Selling</value>
            <value>K</value>
            <value>K</value>
        </row>
        <row>
            <value>1926</value>
            <value>306</value>
            <value>4</value>
            <value>R&#xE5;ssj&#xF6;</value>
            <value>E-B</value>
            <value>EB</value>
        </row>
        <row>
            <value>1927</value>
            <value>306</value>
            <value>5</value>
            <value>Jonsson</value>
            <value>M</value>
            <value>M</value>
        </row>
        <row>
            <value>1928</value>
            <value>307</value>
            <value>1</value>
            <value>Ball</value>
            <value>Nicholas</value>
            <value>N</value>
        </row>
        <row>
            <value>1929</value>
            <value>307</value>
            <value>2</value>
            <value>Rasoulpour</value>
            <value>Reza J</value>
            <value>RJ</value>
        </row>
        <row>
            <value>1930</value>
            <value>307</value>
            <value>3</value>
            <value>Zablotny</value>
            <value>Carol</value>
            <value>C</value>
        </row>
        <row>
            <value>1931</value>
            <value>307</value>
            <value>4</value>
            <value>Ellis-Hutchings</value>
            <value>Robert</value>
            <value>R</value>
        </row>
        <row>
            <value>1932</value>
            <value>307</value>
            <value>5</value>
            <value>Andrus</value>
            <value>Amanda</value>
            <value>A</value>
        </row>
        <row>
            <value>1933</value>
            <value>307</value>
            <value>6</value>
            <value>Carney</value>
            <value>Edward W</value>
            <value>EW</value>
        </row>
        <row>
            <value>1934</value>
            <value>308</value>
            <value>1</value>
            <value>DeGregorio</value>
            <value>Michael W</value>
            <value>MW</value>
        </row>
        <row>
            <value>1935</value>
            <value>308</value>
            <value>2</value>
            <value>Zerbe</value>
            <value>Robert L</value>
            <value>RL</value>
        </row>
        <row>
            <value>1936</value>
            <value>308</value>
            <value>3</value>
            <value>Wurz</value>
            <value>Gregory T</value>
            <value>GT</value>
        </row>
        <row>
            <value>1937</value>
            <value>309</value>
            <value>1</value>
            <value>Santos</value>
            <value>Tatiana C</value>
            <value>TC</value>
        </row>
        <row>
            <value>1938</value>
            <value>309</value>
            <value>2</value>
            <value>Oliveira</value>
            <value>Moacir F</value>
            <value>MF</value>
        </row>
        <row>
            <value>1939</value>
            <value>309</value>
            <value>3</value>
            <value>Papa</value>
            <value>Paula C</value>
            <value>PC</value>
        </row>
        <row>
            <value>1940</value>
            <value>309</value>
            <value>4</value>
            <value>Dantzer</value>
            <value>Vibeke</value>
            <value>V</value>
        </row>
        <row>
            <value>1941</value>
            <value>309</value>
            <value>5</value>
            <value>Miglino</value>
            <value>Maria A</value>
            <value>MA</value>
        </row>
    </table>
    <table name="article_abstract_paras">
        <column>id</column>
        <column>article_id</column>
        <column>position</column>
        <column>heading</column>
        <column>nlm_category</column>
        <column>para</column>
        <row>
            <value>1</value>
            <value>1</value>
            <value>1</value>
            <value></value>
            <value>Unlabelled</value>
            <value></value>
        </row>
        <row>
            <value>461</value>
            <value>243</value>
            <value>1</value>
            <value></value>
            <value></value>
            <value>Pancytopenia is a common occurrence in pediatric patients. Though acute leukemias and bone marrow
                failure syndromes are usual causes of pancytopenia, etiologies such as infections and megaloblastic
                anemia also contribute. The aim of this study was to evaluate the clinico-hematological profile of
                varying degrees of childhood cytopenias with special reference to the non-malignant presentations. This
                is a retrospective study carried out in a tertiary care children's hospital. We retrospectively analyzed
                109 pediatric patients who presented with pancytopenia for different etiologies. Acute leukemia
                (including ALL, AML and myelodysplastic syndrome) and aplastic anemia accounted for 21 per cent and 20
                per cent cases respectively. Megaloblastic anemia was found in 31 (28.4 per cent) patients and was
                single most common etiological factor. Severe thrombocytopenia (platelet &lt; or = 20 x 10(9)/l)
                occurred in 25.2 per cent of these patients. Various skin and mucosal bleeding occurred in 45.1 per cent
                of patients with megaloblastic anemia. Infections accounted for 23 (21 per cent) patients who presented
                with pancytopenia. Amongst infections, enteric fever occurred in 30 per cent patients. Malaria,
                kala-azar and bacterial infections were other causes of pancytopenia at presentation. The study focuses
                on identifying easily treatable causes such as megaloblastic anemia and infections presenting with
                pancytopenia. These conditions though look ominous but respond rapidly to effective therapy.
            </value>
        </row>
        <row>
            <value>467</value>
            <value>246</value>
            <value>1</value>
            <value>Objective</value>
            <value>Objective</value>
            <value>To determine the spectrum of pancytopenia with its frequency, common clinical presentation and
                etiology on the basis of bone marrow examination in children from 2 months to 15 years.
            </value>
        </row>
        <row>
            <value>468</value>
            <value>246</value>
            <value>2</value>
            <value>Design</value>
            <value>Methods</value>
            <value>Observational study.</value>
        </row>
        <row>
            <value>469</value>
            <value>246</value>
            <value>3</value>
            <value>Place and duration of study</value>
            <value>Methods</value>
            <value>Department of Paediatrics, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, from
                October 2005 to March 2007.
            </value>
        </row>
        <row>
            <value>470</value>
            <value>246</value>
            <value>4</value>
            <value>Patients and methods</value>
            <value>Methods</value>
            <value>All patients aged 2 months to 15 years having pancytopenia were included. Patients beyond this age
                limits, already diagnosed cases of aplastic anemia and leukemia, clinical suspicion of genetic or
                constitutional pancytopenia, history of blood transfusion in recent past, and those not willing for
                either admission or bone marrow examination were excluded. History, physical and systemic examination
                and hematological parameters at presentation were recorded. Hematological profile included hemoglobin,
                total and differential leucocyte count, platelet count, reticulocyte count, peripheral smear and bone
                marrow aspiration/biopsy.
            </value>
        </row>
        <row>
            <value>471</value>
            <value>246</value>
            <value>5</value>
            <value>Results</value>
            <value>Results</value>
            <value>During the study period, out of the 7000 admissions in paediatric ward, 250 patients had pancytopenia
                on their peripheral blood smear (3.57%). Out of those, 230 patients were finally studied. Cause of
                pancytopenia was identified in 220 cases on the basis of bone marrow and other supportive
                investigations, while 10 cases remained undiagnosed. Most common was aplastic anemia (23.9%),
                megaloblastic anemia (13.04%), leukemia (13.05%), enteric fever (10.8%), malaria (8.69%) and sepsis
                (8.69%). Common clinical presentations were pallor, fever, petechial hemorrhages, visceromegaly and
                bleeding from nose and gastrointestinal tract.
            </value>
        </row>
        <row>
            <value>472</value>
            <value>246</value>
            <value>6</value>
            <value>Conclusion</value>
            <value>Conclusions</value>
            <value>Pancytopenia is a common occurrence in paediatric patients. Though acute leukemia and bone marrow
                failure were the usual causes of pancytopenia, infections and megaloblastic anemia are easily treatable
                and reversible.
            </value>
        </row>
        <row>
            <value>586</value>
            <value>306</value>
            <value>1</value>
            <value>Objective</value>
            <value>Objective</value>
            <value>To compare single- with double-layer closure of the uterus for the risk of uterine rupture in women
                attempting vaginal birth after one prior caesarean delivery.
            </value>
        </row>
        <row>
            <value>587</value>
            <value>306</value>
            <value>2</value>
            <value>Design</value>
            <value>Methods</value>
            <value>Cohort study.</value>
        </row>
        <row>
            <value>588</value>
            <value>306</value>
            <value>3</value>
            <value>Setting</value>
            <value>Methods</value>
            <value>Sweden.</value>
        </row>
        <row>
            <value>589</value>
            <value>306</value>
            <value>4</value>
            <value>Population</value>
            <value>Methods</value>
            <value>From a total of 19&#xA0;604 nulliparous women delivered by caesarean section in the years 2001-2007,
                7683 women attempting vaginal birth in their second delivery were analysed.
            </value>
        </row>
        <row>
            <value>590</value>
            <value>306</value>
            <value>5</value>
            <value>Methods</value>
            <value>Methods</value>
            <value>Data from population-based registers were linked to hospital-based registers that held data from
                maternity and delivery records. Logistic regression was used to estimate the risk of uterine rupture
                after single- or double-layer closure of the uterus. Results are presented as odds ratios (ORs) with 95%
                confidence intervals (95% CIs).
            </value>
        </row>
        <row>
            <value>591</value>
            <value>306</value>
            <value>6</value>
            <value>Main outcome measure</value>
            <value>Methods</value>
            <value>Uterine rupture.</value>
        </row>
        <row>
            <value>592</value>
            <value>306</value>
            <value>7</value>
            <value>Results</value>
            <value>Results</value>
            <value>Uterine rupture during labour occurred in 103 (1.3%) women. There was no increased risk of uterine
                rupture when single- was compared with double-layer closure of the uterus (OR&#xA0;1.17; 95% CI
                0.78-1.76). Maternal factors associated with uterine rupture were: age &#x2265;35&#xA0;years and height
                &#x2264;160&#xA0;cm. Factors from the first delivery associated with uterine rupture in a subsequent
                delivery were: infection and giving birth to an infant large for gestational age. Risk factors from the
                second delivery were induction of labour, use of epidural analgesia, and a birthweight of &#x2265;4500&#xA0;g.
            </value>
        </row>
        <row>
            <value>593</value>
            <value>306</value>
            <value>8</value>
            <value>Conclusions</value>
            <value>Conclusions</value>
            <value>There was no significant difference in the rate of uterine rupture when single-layer closure was
                compared with double -layer closure of the uterus.
            </value>
        </row>
        <row>
            <value>594</value>
            <value>307</value>
            <value>1</value>
            <value></value>
            <value>Unlabelled</value>
            <value>In rats, 2-amino-2-methylpropanol (AMP) caused an increase in postimplantation loss in an oral
                reproductive/developmental toxicity screening assay but not in a dermal developmental toxicity assay.
                Studies were performed to characterize the mode of action and determine whether the postimplantation
                loss was a result of direct embryotoxicity or a maternally mediated effect. The studies identified that
                the postimplantation loss occurs shortly after implantation, has a steep dose response with a clear
                threshold, requires exposure to AMP for a period of approximately 2-3 weeks prior to gestation and does
                not involve direct embryo toxicity. The uterine histopathology and gene array analysis of decidual
                swellings suggested AMP acts via a maternally mediated mechanism affecting the ability of the uterus to
                support an implanted embryo. Since the postimplantation loss occurs only at maternally toxic doses, the
                implications for human risk assessment are discussed.
            </value>
        </row>
        <row>
            <value>595</value>
            <value>308</value>
            <value>1</value>
            <value></value>
            <value>Unlabelled</value>
            <value>Ospemifene is a selective estrogen receptor modulator (SERM) approved for the treatment of
                dyspareunia associated with vulvar and vaginal atrophy (VVA) due to menopause. As the first non-hormonal
                treatment for this indication, the approval of ospemifene represents a significant milestone in
                postmenopausal women's health. Ospemifene is a triphenylethylene similar in chemical structure to
                tamoxifen and toremifene. Consistent with other SERMs such as tamoxifen, toremifene, and raloxifene,
                ospemifene possesses a distinctive mix of estrogenic and antiestrogenic tissue-specific effects in bone,
                breast tissue, serum lipids, and the vagina. Among the approved SERMs, ospemifene is the only agent with
                a nearly full estrogen agonist effect on the vaginal epithelium while having neutral to slight
                estrogenic effects in the endometrium, making ospemifene uniquely suited for the treatment of
                dyspareunia associated with VVA, also known as atrophic vaginitis, which affects up to 50% of
                postmenopausal women. This review begins with a brief history of the discovery of ospemifene, its
                mechanism of action, and its preclinical development, with an emphasis on its tissue-specific effects on
                bone, breast, uterus and endometrium, serum lipids and vagina. Abrief discussion on the genotoxicity of
                ospemifene compared to tamoxifen and toremifene is included. The focus then shifts to the clinical
                development of ospemifene from Phase I through Phase III. We will close with the FDA approval of
                ospemifene and a justificationof the future clinical evaluation of ospemifene as a potential breast
                cancer chemopreventive agent, where several preclinical studies in different rodent breast cancer models
                strongly suggest ospemifene is as effective as tamoxifen.
            </value>
        </row>
        <row>
            <value>596</value>
            <value>309</value>
            <value>1</value>
            <value></value>
            <value>Unlabelled</value>
            <value>Vascular endothelial growth factor (VEGF) is known to induce endothelial cell proliferation, to
                promote cell migration, and to inhibit apoptosis, thus playing a central role in angiogenesis and in the
                regulation of vasculogenesis. The expression of the VEGF-ligand receptor system was studied in the
                placenta and uterus of the collared peccary in nonpregnant females in the luteal phase and throughout
                pregnancy (&gt;35, 75, 115, and 135&#xA0;days). The material was examined by immunohistochemistry and by
                real-time reverse transcription polymerase chain reaction. Intense positive immunolabeling was observed
                for VEGF and its receptors in the uterine epithelium, uterine glands, and trophoblast. The endothelial
                cells and smooth muscle cells in the maternal and fetal vessels, as well as the connective tissue and
                mesenchyme, had weak immunoreactivity during all periods of pregnancy. The regression analysis of the
                real-time polymerase chain reaction results demonstrated cubic behavior, showing a specific
                time-dependent profile during pregnancy, which increased over the last gestational period to VEGF and
                VEGFR-1. The relative expression of VEGFR-2 decreased in the middle-third of the pregnancy and increased
                in late pregnancy. In the collared peccary, the expression of the VEGF-ligand receptor system was
                similar to that in porcine and ruminant placentas, suggesting that an epitheliochorial placenta has the
                same physiological and interhemal barrier during vascular gestational development. The expression of
                VEGF among cells not related to the vascular system, such as those of the uterine epithelium,
                trophoblast, and uterine glands, suggests a distinct regulatory role for these cells in vasculogenesis
                and also a different role of VEGF pathway.
            </value>
        </row>
    </table>
    <table name="roles">
        <column>id</column>
        <column>role</column>
        <row>
            <value>1</value>
            <value>User</value>
        </row>
        <row>
            <value>2</value>
            <value>Moderator</value>
        </row>
        <row>
            <value>3</value>
            <value>Admin</value>
        </row>
    </table>
    <table name="socials">
        <column>id</column>
        <column>name</column>
        <row>
            <value>1</value>
            <value>Facebook</value>
        </row>
        <row>
            <value>2</value>
            <value>Google</value>
        </row>
    </table>
    <table name="users">
        <column>id</column>
        <column>role</column>
        <column>created_on</column>
        <column>last_logged_in</column>
        <row>
            <value>1</value>
            <value>3</value>
            <value>2014-07-20 18:28:27</value>
            <value>2014-07-24 19:42:03</value>
        </row>
        <row>
            <value>2</value>
            <value>2</value>
            <value>2014-07-20 18:35:38</value>
            <value>2014-07-24 18:54:32</value>
        </row>
        <row>
            <value>3</value>
            <value>1</value>
            <value>2014-07-20 18:56:10</value>
            <value>2014-07-21 03:21:26</value>
        </row>
        <row>
            <value>4</value>
            <value>1</value>
            <value>2014-07-20 19:26:12</value>
            <value>2014-07-20 19:26:12</value>
        </row>
        <row>
            <value>5</value>
            <value>1</value>
            <value>2014-07-22 17:18:14</value>
            <value>2014-07-22 17:18:14</value>
        </row>
        <row>
            <value>6</value>
            <value>1</value>
            <value>2014-07-23 14:46:04</value>
            <value>2014-07-24 18:54:18</value>
        </row>
    </table>
    <table name="user_emails">
        <column>email</column>
        <column>user_id</column>
        <row>
            <value>vikramraj87@gmail.com</value>
            <value>1</value>
        </row>
        <row>
            <value>dr.vikramraj87@gmail.com</value>
            <value>1</value>
        </row>
        <row>
            <value>kirthiviswanath@gmail.com</value>
            <value>2</value>
        </row>
        <row>
            <value>kvartandcrafts@gmail.com</value>
            <value>2</value>
        </row>
        <row>
            <value>kirthika2203@gmail.com</value>
            <value>3</value>
        </row>
        <row>
            <value>ishuips6@gmail.com</value>
            <value>4</value>
        </row>
        <row>
            <value>gpkumaran@gmail.com</value>
            <value>5</value>
        </row>
        <row>
            <value>sumangalagopinathan@gmail.com</value>
            <value>6</value>
        </row>
    </table>
    <table name="user_socials">
        <column>user_id</column>
        <column>social_id</column>
        <column>social</column>
        <row>
            <value>1</value>
            <value>109671001037346774242</value>
            <value>2</value>
        </row>
        <row>
            <value>1</value>
            <value>702348216485397</value>
            <value>1</value>
        </row>
        <row>
            <value>2</value>
            <value>10201596577796234</value>
            <value>1</value>
        </row>
        <row>
            <value>2</value>
            <value>102623028356905318282</value>
            <value>2</value>
        </row>
        <row>
            <value>3</value>
            <value>116662090606954236795</value>
            <value>2</value>
        </row>
        <row>
            <value>4</value>
            <value>109057272140035741568</value>
            <value>2</value>
        </row>
        <row>
            <value>5</value>
            <value>702348216485378</value>
            <value>1</value>
        </row>
        <row>
            <value>6</value>
            <value>106904554194481876715</value>
            <value>2</value>
        </row>
    </table>
    <table name="collections">
        <column>id</column>
        <column>user_id</column>
        <column>name</column>
        <column>created_on</column>
        <column>updated_on</column>
        <row>
            <value>16</value>
            <value>3</value>
            <value>rwss abc</value>
            <value>2014-07-20 19:14:27</value>
            <value>2014-07-20 19:19:42</value>
        </row>
        <row>
            <value>26</value>
            <value>1</value>
            <value>Pancytopenia in septicemia</value>
            <value>2014-07-24 01:00:37</value>
            <value>2014-07-24 01:07:57</value>
        </row>
        <row>
            <value>28</value>
            <value>2</value>
            <value>Uterus</value>
            <value>2014-08-06 07:17:06</value>
            <null/>
        </row>
        <row>
            <value>50</value>
            <value>1</value>
            <value>New Collection</value>
            <null/>
            <null/>
        </row>
        <row>
            <value>53</value>
            <value>1</value>
            <value>New Collection 2</value>
            <null/>
            <null/>
        </row>
        <row>
            <value>153</value>
            <value>1</value>
            <value>New Collection 3</value>
            <null/>
            <null/>
        </row>
        <row>
            <value>155</value>
            <value>1</value>
            <value>New Collection 4</value>
            <null/>
            <null/>
        </row>
    </table>
    <table name="collection_articles">
        <column>collection_id</column>
        <column>article_id</column>
        <column>position</column>
        <row>
            <value>16</value>
            <value>1</value>
            <value>1</value>
        </row>
        <row>
            <value>26</value>
            <value>243</value>
            <value>1</value>
        </row>
        <row>
            <value>26</value>
            <value>246</value>
            <value>2</value>
        </row>
        <row>
            <value>26</value>
            <value>248</value>
            <value>3</value>
        </row>
        <row>
            <value>28</value>
            <value>306</value>
            <value>1</value>
        </row>
        <row>
            <value>28</value>
            <value>307</value>
            <value>2</value>
        </row>
        <row>
            <value>28</value>
            <value>308</value>
            <value>3</value>
        </row>
        <row>
            <value>28</value>
            <value>309</value>
            <value>4</value>
        </row>
    </table>
</dataset>